ConductScience.org, home

Library / Genes

SKP2: S-phase kinase associated protein 2

1 protein, 30 patents, 0 drugs, 0 trials, 2,762 NIH grants and 5,345 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolSKP2HGNC
NameS-phase kinase associated protein 2HGNC
NCBI Gene ID6502NCBI Gene
HGNC IDHGNC:10901HGNC
EnsemblENSG00000145604NCBI Gene
AliasesFBL1, FBXL1, FLB1, p45NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q13309S-phase kinase-associated protein 242426Ensembl, GeneID, HGNCUniProt

Patents 30

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4810514 A12026-09-2347Q13309Espacenet
JP 2026004568 A2026-01-1465269Q13309Espacenet
EP 4650780 A22025-11-192895Q13309Espacenet
JP 2025517970 A2025-06-122895Q13309Espacenet
US 11446398 B22022-09-2083388Q13309Espacenet
JP 2022524081 A2022-04-27186359Q13309Espacenet
US 11078496 B22021-08-039Q13309Espacenet
JP 2019054813 A2019-04-11245704Q13309Espacenet
US 10067143 B22018-09-043Q13309Espacenet
US 10024865 B22018-07-173Q13309Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 2762

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant442,025NIH's project files
P30CA008748Cancer Center Support Grant192,025NIH's project files
P30CA016087Cancer Center Support Grant182,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)182,025NIH's project files
R01AG011085Ubiquitin‐mediated proteolysis and cell cycle control182,025NIH's project files
P30CA016056Roswell Park Cancer Center Support Grant132,025NIH's project files
P30DK050306Center for Molecular Studies in Digestive and Liver Diseases132,025NIH's project files
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant112,025NIH's project files
P30CA016520Abramson Cancer Center Support Grant92,025NIH's project files
P30CA054174Mays Cancer Center at UT Health SA92,025NIH's project files

Papers 5345

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42774987PubTator, text miningPubMed
42750038PubTator, text miningPubMed
42735764PubTator, text miningPubMed
42671015PubTator, text miningPubMed
42665558PubTator, text miningPubMed
42658299PubTator, text miningPubMed
42635941PubTator, text miningPubMed
42620280PubTator, text miningPubMed
42610128PubTator, text miningPubMed
42583384PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license